More OncoSil Medical Ltd news OncoSil Medical LtdASX: OSL Specialised Therapeutics Australia supporting OncoSil study Apr 19, 2017 at 11:52 PM EDT · Issued by OncoSil Medical Ltd Filed with ASX · Apr 19, 2017 at 11:52 PM EDTOn 6ix: 6ix.com/news/specialised-therapeutics-australia-supporting-oncosil-studyOncosil Medical Ltd has released a press release. View Attachment6ix hasn’t read this filing yet. Read this filing OncoSil Medical Ltd on 6ix Earlier from OncoSil MedicalUS IRB Approval, MD Anderson Cancer CentreApr 18, 2017UK Central Ethics ApprovalApr 4, 2017First subject recruitedMar 27, 2017Appendix 4D & Half Year AccountsFeb 22, 2017MHRA Approval to commence study in UKFeb 12, 2017Later from OncoSil MedicalFirst OncoSil Device Implantation procedure completedApr 25, 2017Appendix 4C and Quarterly updateApr 26, 2017Second subject recruited at Monash Health MelbourneMay 10, 2017CE Mark & Quarterly Activity UpdateJul 30, 2017First UK subject recruitedAug 21, 2017All OncoSil Medical news releases↗Follow OncoSil Medical into a list and get an email when it puts out news.Follow OncoSil Medical